Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728591) titled 'Blood-based sEV Proteins for Early Detection of 2 Diabetes' on July 22.
Study Type: Observational
Primary Sponsor: Hong Kong Baptist University
Condition:
Obesity & Overweight
Prediabetes / Type 2 Diabetes
Recruitment Status: Not recruiting
Date of First Enrollment: October 2026
Target Sample Size: 120
Countries of Recruitment:
China
Hong Kong
China
Hong Kong
To know more, visit https://clinicaltrials.gov/study/NCT07728591
Disclaimer: Curated by HT Syndication....